Cases of RSV, flu, COVID, and norovirus are on rise

Moderna laid out sales expectations for the coming year on Monday that were below even the much-diminished Wall Street ...
Speculation about the alleged findings of a study on long COVID and post-vaccination syndrome spread widely among vaccine ...
After a relatively slow start to the respiratory virus season, Covid-19 levels in the United States began ramping up just ...
The HMPV symptoms are primarily mild cold, but in high-risk groups, they can escalate to bronchiolitis or pneumonia, which is ...
Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda ...
Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.
The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...
In 2023, the WHO estimated that the real death toll of the pandemic was at least 20 million Covid-19: over 7 million deaths ...
It's hard to believe it's been five years since the start of COVID-19. This timeline serves as a reminder of those early days ...
Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of its respiratory syncytial virus (RSV) ...